AI & Healthcare News — 2026-10-17 (Sat) Morning News

Overview

Headlines this period were mostly about structure (regulation, care-sector tools, preventive-medicine infrastructure) rather than measured health outcomes. Mental health coverage focused on access and AI-related anxiety, and body health coverage on prediction, monitoring and fatigue detection. The headlines give no sample sizes or trial results, so the evidence stage is unclear for nearly all items.

Mental health

- A Substack piece asks "Can AI solve our mental health access problem?" It is a question, not a finding (Substack). - A report says AI-driven workforce changes create anxiety but may offer opportunities (6abc Philadelphia). - A segment on "AI Anxiety" ties it to Big Tech earnings. This concerns market sentiment, not clinical measurement (Bloomberg). - A local item is titled "AI'S Impact on Depression." The headline gives no data or study design (Your Wyoming Link). - A study reportedly finds music helps AI read brain signals of mental fatigue. The headline does not give the sample size or setting, so the evidence stage is unknown (Bioengineer.org).

Exercise and physical activity

- Deyi Medical, an AI physiotherapy robot maker, raised "tens of millions" in a Series A extension. This is a funding event, not evidence of rehabilitation outcomes (Dealroom). - Wearable electronics combined with machine learning are being used to catch operator fatigue before it turns dangerous. No detection rate or study design is given (Bioengineer.org).

Sleep

No notable developments.

Nutrition and diet

No notable developments.

Prevention and screening

- AI reportedly reads the heart's "forgotten chamber" to predict death and disease. The headline does not name the population or evidence stage (Bioengineer.org). - Free AI eye checks are offered in Nessebar on October 28. This is a community screening event, and no results are reported (BurgasMedia). - Japan's Ministry of Health, Labour and Welfare will build a system to promote preventive medicine with AI (Fukushima Minpo Digital). 【Chronic disease self-management】 - Old Dominion University and CHKD are using AI and geospatial data to understand childhood asthma disparities. This is an analytic effort, and the headline reports no outcomes (Old Dominion University).

Older adults and care

- AI home sensors could help older people live independently. The headline suggests potential, not demonstrated results (Digital Health). - A Memphis nonprofit is helping older adults learn about AI (FOX13 Memphis). - A company uses AI to impersonate elderly people and lure scammers into traps (36Kr). - AI-generated digital personas exploit elderly consumers in China (OECD AI Policy Observatory). - AI reportedly identified the SRSF1 gene, which extended the lifespan of aged mice by 14%. This is preclinical, animal-model evidence only (BigGo Finance, DongA Science). 【Digital therapeutics and regulation】 - The UK's MHRA has set out an AI regulation overhaul. The coverage asks whether faster approvals will deliver faster NHS adoption (politicsuk.com). - An expert says AI could expand access to weight loss drugs and improve patient outcomes. This is an expert's view, not trial evidence (Health Tech World).

Workplace health

- A "burnout trade" has emerged as investors grow tired of debating tech's promises. This is about investor fatigue, not worker health (MarketWatch). - AI adoption is gaining ground in the GCC, but HR ownership remains rare (HR Executive). - Organizations are paying for AI while employees keep doing the old job (HR Executive). - A piece sets out what HR leaders need to do now under the EU AI Act (HR Executive).

Developments in Japan

- An AI shift-scheduling feature has been added to MentCare, an AI mentor for care providers (PR TIMES). - Rehab Cloud offers an AI support chat to answer questions at care sites (VOIX). - Japan's Ministry of Health, Labour and Welfare will build an AI-based preventive-medicine system (Fukushima Minpo Digital).

Statements by key figures

No notable developments.

AI videos and explainers

No notable developments.